Old Web
English
Sign In
Acemap
>
authorDetail
>
Richard Aplenc
Richard Aplenc
University of California, Los Angeles
Medicine
Myeloid leukemia
Internal medicine
Cancer research
CD33
4
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
advanced CD33+ acute myeloid leukemia Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with
2013
Irwin D. Bernstein
Eric L. Sievers
Terry Vik
David Flowers
Richard Aplenc
Mark S. Berger
Matthew L. Sherman
Robert J. Arceci
Jane Sande
Beverly J. Lange
Kevin M. Shannon
Janet Franklin
Raymond J. Hutchinson
Show All
Source
Cite
Save
Citations (0)
patients with advanced CD33-positive acute myeloid leukemia Safety and efficacy of gemtuzumab ozogamicin (Mylotarg®) in pediatric
2010
Eric L. Sievers
David Flowers
Richard Aplenc
Mark S. Berger
Matthew L. Sherman
Franklin O. Smith
Irwin Robert
J Arceci
Jane Sande
Beverly J. Lange
Kevin M. Shannon
Janet Franklin
Raymond J. Hutchinson
Show All
Source
Cite
Save
Citations (0)
Pilot Study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941
2004
Journal of Clinical Oncology
Beverly Lange
Patricia Dinndorf
Franklin O. Smith
Carola A.S. Arndt
Dorothy Barnard
Stephen A. Feig
James Feusner
Nita Seibel
Margie Weiman
Richard Aplenc
Robert Gerbing
Todd A. Alonzo
Show All
Source
Cite
Save
Citations (37)
Classification and Diagnosis
2003
Richard Aplenc
Beverly Lange
Show All
Source
Cite
Save
Citations (0)
1